ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM
NEW YORK, June 25, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Axsome Therapeutics, Inc. (NASDAQ: AXSM) between December 30, 2019 and April 22, 2022, inclusive (the “Class Period”), of the important July 12, 2022 lead plaintiff deadline. SO WHAT: If you purchased Axsome securities during the […]